APA ציטוט

Luskin, M. R., Lee, J., Fernandez, H. F., Abdel-Wahab, O., Bennett, J. M., Ketterling, R. P., . . . Luger, S. M. (2016). Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood.

Citação norma Chicago

Luskin, Marlise R., et al. "Benefit of High-dose Daunorubicin in AML Induction Extends Across Cytogenetic and Molecular Groups." Blood 2016.

ציטוט MLA

Luskin, Marlise R., et al. "Benefit of High-dose Daunorubicin in AML Induction Extends Across Cytogenetic and Molecular Groups." Blood 2016.